ALKS Insider Transactions
756 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
ALKS insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Nichols Christian Todd | SVP, Chief Commercial Officer | 2026-08-17 | Sale | 664 | $49.6526 |
| Nichols Christian Todd | SVP, Chief Commercial Officer | 2026-08-17 | Sale | 6,912 | $49.1851 |
| snyderman nancy lynn MD | Director | 2026-08-03 | Sale | 44,472 | $50.348 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2026-08-03 | Sale | 9,000 | $48.58 |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 2026-08-03 | Sale | 2,034 | $48.58 |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 2026-07-06 | Sale | 2,034 | $54.03 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2026-07-01 | Sale | 700 | $52.1314 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2026-07-01 | Sale | 8,300 | $51.4613 |
| Wright Christopher I | Director | 2026-06-12 | Sale | 2,000.0 | $45.1 |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 2026-06-04 | Sale | 2,034.0 | $43.05 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2026-06-01 | Sale | 9,000.0 | $41.67 |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | 2026-05-29 | Sale | 16,217.0 | $42.36 |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 2026-05-04 | Sale | 2,034.0 | $33.2 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2026-05-01 | Sale | 9,000.0 | $33.4 |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 2026-04-06 | Sale | 2,034.0 | $34.57 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2026-04-01 | Sale | 9,000.0 | $35.51 |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 2026-03-03 | Sale | 2,034.0 | $29.76 |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | 2026-03-02 | Sale | 6,890.0 | $29.29 |
| Nichols Christian Todd | SVP, Chief Commercial Officer | 2026-03-02 | Sale | 6,000.0 | $30.0 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2026-03-02 | Sale | 9,000.0 | $29.72 |
| Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 2026-03-02 | Sale | 2,034.0 | $29.29 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2026-02-02 | Sale | 4,000.0 | $33.54 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2026-02-02 | Sale | 5,000.0 | $34.24 |
| Cooke Shane | Director | 2026-02-02 | Sale | 32,113.0 | $34.78 |
| Cooke Shane | Director | 2026-02-02 | Sale | 29,087.0 | $34.34 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2026-01-08 | Sale | 5,000.0 | $30.0 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2026-01-02 | Sale | 4,000.0 | $28.0 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2025-12-03 | Sale | 3,748.0 | $30.0 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2025-12-01 | Sale | 4,000.0 | $29.3 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2025-11-03 | Sale | 9,000.0 | $30.38 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2025-10-15 | Sale | 9,000.0 | $31.53 |
| Nichols Christian Todd | SVP, Chief Commercial Officer | 2025-06-10 | Sale | 3,334.0 | $31.09 |
| Nichols Christian Todd | SVP, Chief Commercial Officer | 2025-06-09 | Sale | 3,333.0 | $31.95 |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | 2025-02-28 | Sale | 1,938.0 | $34.0 |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | 2025-02-25 | Sale | 3,743.0 | $35.26 |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | 2025-02-20 | Sale | 1,327.0 | $35.69 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2025-02-13 | Sale | 108,833.0 | $36.02 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2025-02-13 | Sale | 35,586.0 | $34.02 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2025-02-12 | Sale | 33,108.0 | $33.27 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2025-02-12 | Sale | 171,813.0 | $32.69 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2025-01-30 | Sale | 100,918.0 | $32.05 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2024-12-09 | Sale | 61,151.0 | $32.07 |
| LAURENCIN CATO T | Director | 2024-12-09 | Sale | 2,691.0 | $31.85 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2024-12-05 | Sale | 9,221.0 | $31.5 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2024-12-04 | Sale | 14,349.0 | $30.77 |
| Nichols Christian Todd | SVP, Chief Commercial Officer | 2024-11-27 | Sale | 5,208.0 | $29.15 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2024-11-11 | Sale | 58,996.0 | $30.08 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2024-11-06 | Sale | 10,471.0 | $29.53 |
| Nichols Christian Todd | SVP, Chief Commercial Officer | 2024-03-18 | Sale | 10,417.0 | $28.1 |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | 2024-02-27 | Sale | 2,559.0 | $29.65 |
| LAURENCIN CATO T | Director | 2024-02-15 | Sale | 2,690.0 | $31.85 |
| LAURENCIN CATO T | Director | 2023-06-08 | Sale | 2,638.0 | $31.85 |
| LAURENCIN CATO T | Director | 2023-06-07 | Sale | 2,800.0 | $31.5 |
| Nichols Christian Todd | SVP, Chief Commercial Officer | 2023-05-30 | Sale | 27,134.0 | $28.93 |
| Wysenski Nancy | Director | 2023-05-09 | Sale | 41,250.0 | $31.24 |
| Daglio David Angelo Jr. | Director | 2022-11-14 | Purchase | 35,000.0 | $23.31 |
| Nichols Christian Todd | SVP, Chief Commercial Officer | 2022-06-21 | Sale | 7,474.0 | $28.26 |
| LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | 2022-05-17 | Sale | 50,000.0 | $29.15 |
| LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | 2022-05-10 | Sale | 25,000.0 | $27.22 |
| POPS RICHARD F | Director and CEO, Alkermes plc | 2022-05-06 | Sale | 93,747.0 | $27.85 |
| POPS RICHARD F | Director and CEO, Alkermes plc | 2022-05-05 | Sale | 32,288.0 | $28.59 |
| POPS RICHARD F | Director and CEO, Alkermes plc | 2022-05-05 | Sale | 221,222.0 | $27.95 |
| LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | 2022-05-03 | Sale | 25,000.0 | $28.62 |
| Cooke Shane | Director | 2022-05-02 | Sale | 10,000.0 | $29.23 |
| Cooke Shane | Director | 2022-04-25 | Sale | 10,000.0 | $27.88 |
| Jackson Blair Curtis | EVP, Chief Operating Officer | 2022-04-20 | Sale | 49,999.0 | $29.61 |
| Cooke Shane | Director | 2022-04-18 | Sale | 10,000.0 | $28.88 |
| Cooke Shane | Director | 2022-04-11 | Sale | 10,000.0 | $29.26 |
| Cooke Shane | Director | 2022-04-04 | Sale | 10,000.0 | $28.18 |
| snyderman nancy lynn MD | Director | 2022-03-04 | Purchase | 427.0 | $23.43 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2022-02-23 | Sale | 11,983.0 | $24.76 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2022-02-18 | Sale | 2,306.0 | $25.17 |
| Alva Emily Peterson | Director | 2021-08-23 | Purchase | 1,650.17 | $30.22 |
| Brown Iain Michael | SVP, Chief Financial Officer | 2021-08-19 | Sale | 40,000.0 | $29.99 |
| MCKEON BRIAN P | Director | 2021-08-02 | Purchase | 10,000.0 | $26.43 |
| Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | 2021-07-29 | Sale | 14,000.0 | $26.0 |
| ANSTICE DAVID W | Director | 2021-07-01 | Sale | 20,000.0 | $24.58 |
| Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | 2021-06-10 | Sale | 13,500.0 | $25.0 |
| DIXON WENDY L | Director | 2021-06-10 | Sale | 25,000.0 | $25.0 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2021-06-09 | Sale | 882.0 | $24.6 |
| Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | 2021-06-07 | Sale | 13,500.0 | $24.0 |
| ANSTICE DAVID W | Director | 2021-06-07 | Sale | 5,000.0 | $24.0 |
| POPS RICHARD F | Director and CEO, Alkermes plc | 2021-05-18 | Sale | 150,000.0 | $21.9 |
| LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | 2021-05-17 | Sale | 50,000.0 | $22.09 |
| Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | 2021-05-14 | Sale | 2,250.0 | $22.23 |
| LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | 2021-05-13 | Sale | 25,000.0 | $22.39 |
| POPS RICHARD F | Director and CEO, Alkermes plc | 2021-05-11 | Sale | 60,297.0 | $22.3 |
| POPS RICHARD F | Director and CEO, Alkermes plc | 2021-05-11 | Sale | 89,703.0 | $21.95 |
| LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | 2021-05-07 | Sale | 19,477.0 | $22.1 |
| POPS RICHARD F | Director and CEO, Alkermes plc | 2021-05-06 | Sale | 100,000.0 | $21.79 |
| Jackson Blair Curtis | EVP, Chief Operating Officer | 2021-05-03 | Sale | 34,503.0 | $22.18 |
| DIXON WENDY L | Director | 2021-04-19 | Sale | 25,000.0 | $20.0 |
| Brown Iain Michael | SVP, Chief Financial Officer | 2021-04-19 | Sale | 34,792.0 | $20.0 |
| Brown Iain Michael | SVP, Chief Financial Officer | 2021-04-16 | Sale | 208.0 | $19.99 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 2021-04-15 | Sale | 28,920.0 | $19.72 |
| MITCHELL PAUL J | Director | 2020-10-01 | Sale | 20,000.0 | $16.61 |
| ANSTICE DAVID W | Director | 2020-09-28 | Sale | 17,832.0 | $16.79 |
| POPS RICHARD F | Director and CEO, Alkermes plc | 2020-05-14 | Sale | 75,000.0 | $15.0 |
| Brown Iain Michael | SVP Finance & CAO, Alks Inc. | 2020-05-13 | Sale | 6,250.0 | $15.39 |
| LANDINE MICHAEL J | SVP, Corp Dev., Alkermes, Inc. | 2020-05-12 | Sale | 18,000.0 | $15.75 |